Probing chelation motifs in HIV integrase inhibitors (Q35786972)

10 August 2017

Probing chelation motifs in HIV integrase inhibitors (English)

1 reference

10 August 2017

7

Yves Pommier

1 reference

10 August 2017

Arpita Agrawal

1

1 reference

10 August 2017

Jamie DeSoto

2

1 reference

10 August 2017

Jessica L Fullagar

3

1 reference

10 August 2017

Kasthuraiah Maddali

4

1 reference

10 August 2017

Shahrzad Rostami

5

1 reference

10 August 2017

Douglas D Richman

6

1 reference

10 August 2017

Seth M Cohen

8

1 reference

10 August 2017

language of work or name

English

0 references

publication date

27 January 2012

1 reference

Proceedings of the National Academy of Sciences of the United States of America

10 August 2017

1 reference

10 August 2017

109

1 reference

10 August 2017

2251-2256

1 reference

10 August 2017

7

1 reference

Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Structural biology of retroviral DNA integration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Structure-based modeling of the functional HIV-1 intasome and its inhibition

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Resistance to integrase inhibitors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Retroviral intasome assembly and inhibition of DNA strand transfer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

A dynamic model of HIV integrase inhibition and drug resistance

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

HIV-1 IN inhibitors: 2010 update and perspectives

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Metal chelators as antiviral agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Alkoxyalkyl esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Integrase inhibitors to treat HIV/AIDS.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Structure and function of HIV-1 integrase

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Rational design of sequestering agents for plutonium and other actinides.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Bipyridine: the most widely used ligand. A review of molecules comprising at least two 2,2'-bipyridine units

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289312

Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects.

12 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1112389109

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1112389109

Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1112389109

In vitro human immunodeficiency virus type 1 integrase assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1112389109

Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1112389109

Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1112389109

Potent, selective pyrone-based inhibitors of stromelysin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1112389109

21 January 2018

Identifiers

DOI

10.1073/PNAS.1112389109

1 reference

10 August 2017

0 references

1 reference

10 August 2017

1 reference